Business
Directors' Dealings and Issue of Equity
Directors' Dealings and Issue of Equity.
About this update from Europa Metals Limited
[{"type":"text","content":"\n \n \n \n 24 January 2023\n \n \n \n \n Europa Metals Ltd\n \n \n \n (\"Europa Metals\", the \"Company\" or the \"Group\") (AIM, AltX: EUZ)\n \n \n \n Fee Conversions, Grant of Options and Performance Rights,\n \n \n \n \n Directors' Dealings and Issue of Equity\n \n \n \n Europa Metals, the European focused lead, zinc and silver developer, announces, further to its announcement of 26 January 2022, the conversion by certain of its directors of an aggregate amount of £42,880 of deferred/accrued remuneration for the six month period ended 31 December 2022 into new ordinary shares of no par value in the capital of the Company (\"Ordinary Shares\") (the \"Fee Conversions\"). Pursuant to the Fee Conversions, the Company is today issuing, in aggregate, 1,245,988 new Ordinary Shares (the \"Conversion Shares\") at a blended issue price of approximately 3.44 pence per share as determined by applying the relevant monthly volume weighted average price for the Company's Ordinary Shares on AIM and relevant month end AUD:GBP exchange rate, as applicable, to 50 per cent. of each participating director's fees/salary for the period concerned. Such Fee Conversions conclude the Company's fee deferral and conversion programme.\n \n \n Application will be made to the London Stock Exchange for the abovementioned 1,245,988 Conversion Shares to be admitted to trading on AIM (\"Admission\") and to the Johannesburg Stock Exchange for quotation on AltX. It is expected that Admission will become effective and that dealings in the Conversion Shares will commence at 8.00 a.m. on 30 January 2023.\n \n \n Following Admission, the Company's total issued ordinary share capital will comprise 94,171,790 Ordinary Shares with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to the Company's Constitution.\n \n \n Following Admission, the beneficial shareholdings of the directors receiving Conversion Shares will be as follows:\n \n \n \n \n \n \n \n Director\n \n \n \n \n \n \n Position\n \n \n \n \n \n \n Number of Conversion Shares to be received\n \n \n \n \n \n \n Total number of Ordinary Shares held on Admission\n \n \n \n \n \n \n % of voting rights held on Admission\...